NZ222607A - Heterocyclic - phosphonic acids, preparation therof and pharmaceutical compositions - Google Patents
Heterocyclic - phosphonic acids, preparation therof and pharmaceutical compositionsInfo
- Publication number
- NZ222607A NZ222607A NZ222607A NZ22260787A NZ222607A NZ 222607 A NZ222607 A NZ 222607A NZ 222607 A NZ222607 A NZ 222607A NZ 22260787 A NZ22260787 A NZ 22260787A NZ 222607 A NZ222607 A NZ 222607A
- Authority
- NZ
- New Zealand
- Prior art keywords
- heterocyclic
- carbon
- pharmaceutical compositions
- phosphonic acids
- carboxyl
- Prior art date
Links
- 125000000623 heterocyclic group Chemical group 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N phosphonic acid group Chemical group P(O)(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Quinoline Compounds (AREA)
- Dental Preparations (AREA)
Abstract
Compounds of the formula I <IMAGE> in which one or both of the acidic hydroxyl groups of the phosphonic acid part can be etherified, m is one or zero, R<1> denotes carboxyl, esterified carboxyl or amidated carboxyl, the heterocyclic five- or six-membered ring can additionally be substituted on the carbon and/or nitrogen, can have a carbon-carbon double bond or can be condensed with a carbocyclic 6-membered ring, starting from adjacent carbon atoms, A represents lower alkenylene; and salts thereof. These compounds are suitable as antagonists of the N-methyl-D-aspartate- sensitive amino acid stimulant receptor in mammals.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93370286A | 1986-11-21 | 1986-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ222607A true NZ222607A (en) | 1990-10-26 |
Family
ID=25464377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ222607A NZ222607A (en) | 1986-11-21 | 1987-11-19 | Heterocyclic - phosphonic acids, preparation therof and pharmaceutical compositions |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0275820B1 (en) |
| JP (1) | JPH0686470B2 (en) |
| KR (1) | KR880006195A (en) |
| AT (1) | ATE60776T1 (en) |
| AU (1) | AU610841B2 (en) |
| CA (1) | CA1312608C (en) |
| DD (1) | DD273837A5 (en) |
| DE (1) | DE3768000D1 (en) |
| DK (1) | DK609487A (en) |
| ES (1) | ES2031927T3 (en) |
| FI (1) | FI86638C (en) |
| GR (1) | GR3001443T3 (en) |
| HU (1) | HU199857B (en) |
| IE (1) | IE60534B1 (en) |
| IL (1) | IL84492A0 (en) |
| MX (1) | MX9437A (en) |
| NO (1) | NO170853C (en) |
| NZ (1) | NZ222607A (en) |
| PH (1) | PH25465A (en) |
| PT (1) | PT86168B (en) |
| ZA (1) | ZA878699B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968678A (en) * | 1988-02-19 | 1990-11-06 | Eli Lilly And Company | Tetrazole excitatory amino acid receptor antagonists |
| CA2000901A1 (en) * | 1988-10-21 | 1990-04-21 | Alexis A. Cordi | Phosphono-hydroisoquinoline compounds useful in reducing neurotoxic injury |
| US4902695A (en) * | 1989-02-13 | 1990-02-20 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| EP0424179A3 (en) * | 1989-10-20 | 1991-12-27 | John William Olney | Use of combined excitatory amino acid and cholinergic antagonists to prevent neurological deterioration |
| US5238958A (en) * | 1990-02-26 | 1993-08-24 | Warner-Lambert Company | Substituted α-amino acids having selected acidic moieties for use as excitatory amino acid antagonists in pharmaceuticals |
| US5194430A (en) * | 1990-05-17 | 1993-03-16 | Merrell Dow Pharmaceuticals Inc. | Heterocyclic-nmda antagonists |
| SE9003652D0 (en) * | 1990-11-15 | 1990-11-15 | Astra Ab | NEW HETEROCYCLIC COMPOUNDS |
| US5260286A (en) * | 1992-10-16 | 1993-11-09 | Japan Tobacco, Inc. | 2-piperidinecarboxylic acid derivatives useful as NMDA receptor antagonists |
| EP0988301B1 (en) | 1997-06-12 | 2006-08-09 | Aventis Pharma Limited | Imidazolyl-cyclic acetals |
| EP3427729A1 (en) | 2017-07-13 | 2019-01-16 | Paris Sciences et Lettres - Quartier Latin | Probenecid for use in treating epileptic diseases, disorders or conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2104079B (en) * | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| PH23848A (en) * | 1985-05-24 | 1989-11-23 | Ciba Geigy Ag | Certain phosphonic acids and derivatives |
-
1987
- 1987-11-16 EP EP87810662A patent/EP0275820B1/en not_active Expired - Lifetime
- 1987-11-16 IL IL84492A patent/IL84492A0/en unknown
- 1987-11-16 DE DE8787810662T patent/DE3768000D1/en not_active Expired - Lifetime
- 1987-11-16 AT AT87810662T patent/ATE60776T1/en active
- 1987-11-16 ES ES198787810662T patent/ES2031927T3/en not_active Expired - Lifetime
- 1987-11-18 FI FI875097A patent/FI86638C/en not_active IP Right Cessation
- 1987-11-18 PH PH36083A patent/PH25465A/en unknown
- 1987-11-19 DD DD87309215A patent/DD273837A5/en not_active IP Right Cessation
- 1987-11-19 PT PT86168A patent/PT86168B/en not_active IP Right Cessation
- 1987-11-19 CA CA000552204A patent/CA1312608C/en not_active Expired - Fee Related
- 1987-11-19 NZ NZ222607A patent/NZ222607A/en unknown
- 1987-11-20 IE IE314987A patent/IE60534B1/en not_active IP Right Cessation
- 1987-11-20 AU AU81455/87A patent/AU610841B2/en not_active Ceased
- 1987-11-20 KR KR870013064A patent/KR880006195A/en not_active Application Discontinuation
- 1987-11-20 JP JP62292195A patent/JPH0686470B2/en not_active Expired - Lifetime
- 1987-11-20 HU HU875161A patent/HU199857B/en not_active IP Right Cessation
- 1987-11-20 ZA ZA878699A patent/ZA878699B/en unknown
- 1987-11-20 NO NO874854A patent/NO170853C/en unknown
- 1987-11-20 DK DK609487A patent/DK609487A/en not_active Application Discontinuation
- 1987-11-23 MX MX943787A patent/MX9437A/en unknown
-
1991
- 1991-02-07 GR GR90401113T patent/GR3001443T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU610841B2 (en) | 1991-05-30 |
| IE60534B1 (en) | 1994-07-27 |
| IL84492A0 (en) | 1988-04-29 |
| IE873149L (en) | 1988-05-21 |
| KR880006195A (en) | 1988-07-22 |
| ZA878699B (en) | 1988-05-23 |
| HUT46331A (en) | 1988-10-28 |
| CA1312608C (en) | 1993-01-12 |
| ATE60776T1 (en) | 1991-02-15 |
| PH25465A (en) | 1991-07-01 |
| DK609487A (en) | 1988-05-22 |
| ES2031927T3 (en) | 1993-01-01 |
| EP0275820A3 (en) | 1988-08-03 |
| FI86638B (en) | 1992-06-15 |
| HU199857B (en) | 1990-03-28 |
| JPH0686470B2 (en) | 1994-11-02 |
| EP0275820A2 (en) | 1988-07-27 |
| JPH01135791A (en) | 1989-05-29 |
| DD273837A5 (en) | 1989-11-29 |
| FI875097A (en) | 1988-05-22 |
| FI86638C (en) | 1992-09-25 |
| PT86168A (en) | 1987-12-01 |
| DK609487D0 (en) | 1987-11-20 |
| NO874854L (en) | 1988-05-24 |
| NO170853C (en) | 1992-12-16 |
| AU8145587A (en) | 1988-05-26 |
| NO874854D0 (en) | 1987-11-20 |
| PT86168B (en) | 1990-08-31 |
| MX9437A (en) | 1994-01-31 |
| DE3768000D1 (en) | 1991-03-14 |
| EP0275820B1 (en) | 1991-02-06 |
| GR3001443T3 (en) | 1992-09-25 |
| NO170853B (en) | 1992-09-07 |
| FI875097A0 (en) | 1987-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ222607A (en) | Heterocyclic - phosphonic acids, preparation therof and pharmaceutical compositions | |
| PT82626A (en) | Process for preparing ceryain phosphonil acids and derivatives thereof | |
| FI881892A (en) | Process for the preparation of novel therapeutically useful 1,2,5,6-tetrahydropyridine derivatives | |
| FI871445A0 (en) | FOERFARANDE FOER FRAMSTAELLNING AV NYA SPERGUALINDERIVAT. | |
| SE8200570L (en) | TIAZOLIDE INGREDIENTS WITH PHARMACOLOGICAL ACTIVITY AND PROCEDURE FOR PREPARING THEREOF | |
| ES2000369A6 (en) | Substituted DI-t-butylphenols. | |
| DK161090A (en) | NEW TOPICAL PREPARATION FOR THE TREATMENT OF ALOPECI |